Search Results 351-360 of 16385 for infliximab

1. Envafolimab And Envafolimab With Ipilimumab In Patients With Undifferentiated Pleomorphic Sarcoma Or Myxofibrosarcoma - Mayo Clinic

   About this study. The purpose of this study is determine objective response rate (ORR) by RECIST 1.1 by blinded independent central review (BICR) of ...

2. A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma - Mayo Clinic

   Ongoing treatment with other monoclonal antibodies (e.g., infliximab, rituximab), immunomodulators (eg, abatacept, methotrexate, azathioprine, cyclosporine) ...

3. A Study to Evaluate Expanded Access to Mepolizumab for Patients with Hypereosinophilic Syndrome - Mayo Clinic

   The purpose of this study is to provide a mechanism for expanded access to mepolizumab therapy for eligible patients with Hypereosinophilic Syndrome (HES).

4. Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients with High-Risk Stage III-IV Melanoma that has been Removed by Surgery - Mayo Clinic

   Monoclonal antibodies, such as ipilimumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor ...

5. A Study To Evaluate Acalabrutinib With Or Without Obinutuzumab To Treat Early-Stage Chronic Lymphocytic Leukemia Or Small Lymphocytic Lymphoma Patients - Mayo Clinic

   This phase II trials studies how well acalabrutinib with or without obinutuzumab works in treating participants with early-stage chronic lymphocytic leukemia or ...

6. A Study to Test Long-term Treatment With Brigimadlin in People With Solid Tumours Who Took Part in a Previous Study With This Medicine - Mayo Clinic

   The goal of this study is to find out how well people with solid tumours tolerate long-term treatment with brigimadlin. Brigimadlin is a so-called MDM2 ...

7. Safety and Efficacy of GS-5745 in Participants With Moderately to Severely Active Crohn's Disease - Mayo Clinic

   This study will primarily evaluate the safety and efficacy of GS-5745 in adults with active Crohn's disease. The study will consist of a Blinded Treatment ...

8. A Study Of The Drugs Selumetinib Vs. Carboplatin And Vincristine In Patients With Low-Grade Glioma - Mayo Clinic

   About this study. This study aims to demonstrate that the efficacy of treatment with selumetinib as measured by event-free survival (EFS) is non-inferior ...

9. Lixisenatide (subcutaneous route) - Side effects & dosage - Mayo Clinic

   Lixisenatide injection is used to treat type 2 diabetes mellitus. Lixisenatide is used together with diet and exercise to help control your blood sugar. This ...

10. Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps - Mayo Clinic

    Current or planned use of immunomodulators including: infliximab, 6‐MP (mercaptopurine), methotrexate, cyclosporine, or other immunomodulatory drugs; History ...